{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:56:13Z","timestamp":1790646973245,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12828-1","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:52:57Z","timestamp":1790585577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combination of kale-derived exosomes and dactolisib promotes apoptosis and modulates iron homeostasis in Hep3B hepatocellular carcinoma cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Nurdan Sena","family":"De\u011firmenci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Zor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Ped\u00fck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarife","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Padar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikrettin","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra \u00d6mero\u011flu","family":"Ulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"12828_CR1","unstructured":"Asafo-Agyei KO, Samant H (2023) Hepatocellular carcinoma. StatPearls. StatPearls Publishing, Treasure Island (FL)."},{"key":"12828_CR2","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s12276-020-00527-1","volume":"52","author":"E Kim","year":"2020","unstructured":"Kim E, Viatour P (2020) Hepatocellular carcinoma: old friends and new tricks. Exp Mol Med 52:1898\u20131907","journal-title":"Exp Mol Med"},{"issue":"1","key":"12828_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.soc.2023.06.008","volume":"33","author":"M Patel","year":"2024","unstructured":"Patel M, Pillai A (2024) Management of Intermediate-Stage Hepatocellular Carcinoma: Systemic Versus Locoregional Therapy. Surg Oncol Clin N Am 33(1):159\u2013172. https:\/\/doi.org\/10.1016\/j.soc.2023.06.008","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"12828_CR4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jhep.2021.07.004","volume":"75","author":"J Bruix","year":"2021","unstructured":"Bruix J, Chan SL, Galle PR, Rimassa L, Sangro B (2021) Systemic treatment of hepatocellular carcinoma: an EASL position paper. J Hepatol 75(4):960\u2013974","journal-title":"J Hepatol"},{"issue":"4","key":"12828_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s11523-025-01161-5","volume":"20","author":"F Lo Prinzi","year":"2025","unstructured":"Lo Prinzi F, Rossari F, Silletta M, Camera S, Foti S, Persano M, Vitiello F, Di Giacomo E, Polito MG, Rimini M, Casadei-Gardini A (2025) Comparative Effectiveness of Atezolizumab Plus Bevacizumab Versus Tremelimumab Plus Durvalumab in Patients with Hepatocellular Carcinoma (HCC) in a Real-World Setting. Target Oncol 20(4):707\u2013713. https:\/\/doi.org\/10.1007\/s11523-025-01161-5","journal-title":"Target Oncol"},{"issue":"2","key":"12828_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41419-022-04583-5","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Miao X, Jiang Y, Wu Z, Zhu X, Liu H, Wu X, Cai J, Ding X, Gong W (2022) The synergistic antitumor effect of IL-6 neutralization with NVP-BEZ235 in hepatocellular carcinoma. Cell Death Dis 13(2):146","journal-title":"Cell Death Dis"},{"key":"12828_CR7","doi-asserted-by":"publisher","first-page":"101364","DOI":"10.1016\/j.tranon.2022.101364","volume":"18","author":"M-J Sanaei","year":"2022","unstructured":"Sanaei M-J, Razi S, Pourbagheri-Sigaroodi A, Bashash D (2022) The PI3K\/Akt\/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles. Translational Oncol 18:101364. https:\/\/doi.org\/10.1016\/j.tranon.2022.101364","journal-title":"Translational Oncol"},{"issue":"11","key":"12828_CR8","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/biomedicines9111639","volume":"9","author":"EJ Sun","year":"2021","unstructured":"Sun EJ, Wankell M, Palamuthusingam P, McFarlane C, Hebbard L (2021) Targeting the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma. Biomedicines 9(11):1639. https:\/\/doi.org\/10.3390\/biomedicines9111639","journal-title":"Biomedicines"},{"key":"12828_CR9","doi-asserted-by":"publisher","first-page":"5556306","DOI":"10.1155\/2021\/5556306","volume":"2021","author":"W Cao","year":"2021","unstructured":"Cao W, Liu X, Zhang Y, Li A, Xie Y, Zhou S, Song L, Xu R, Ma Y, Cai S, Tang X (2021) BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K\/AKT\/mTOR and Inducing Autophagy. Biomed Res Int 2021:5556306. https:\/\/doi.org\/10.1155\/2021\/5556306","journal-title":"Biomed Res Int"},{"issue":"12","key":"12828_CR10","first-page":"7255","volume":"11","author":"X Liu","year":"2019","unstructured":"Liu X, Xie C, Li A, Zhang Y, Liu X, Zhou S, Shen J, Huo Z, Cao W, Ma Y, Xu R, Xing Y, Xie Y, Cai S, Tang X (2019) BEZ235 enhances chemosensitivity of paclitaxel in hepatocellular carcinoma through inhibiting the PI3K\/Akt\/mTOR pathway. Am J translational Res 11(12):7255\u20137271","journal-title":"Am J translational Res"},{"key":"12828_CR11","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.2147\/IJN.S390378","volume":"17","author":"Y Wu","year":"2022","unstructured":"Wu Y, Chen W, Guo M, Tan Q, Zhou E, Deng J, Li M, Chen J, Yang Z, Jin Y (2022) Metabolomics of extracellular vesicles: A future promise of multiple clinical applications. Int J Nanomed 17:6113\u20136129. https:\/\/doi.org\/10.2147\/IJN.S390378","journal-title":"Int J Nanomed"},{"key":"12828_CR12","doi-asserted-by":"publisher","first-page":"120467","DOI":"10.1016\/j.biomaterials.2020.120467","volume":"269","author":"P Wu","year":"2021","unstructured":"Wu P, Zhang B, Ocansey DKW, Xu W, Qian H (2021) Extracellular vesicles: A bright star of nanomedicine. Biomaterials 269:120467. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120467","journal-title":"Biomaterials"},{"issue":"12","key":"12828_CR13","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1002\/mco2.70009","volume":"5","author":"Y Ma","year":"2024","unstructured":"Ma Y, Zhang X, Liu C, Zhao Y (2024) Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies. MedComm 5(12):e70009. https:\/\/doi.org\/10.1002\/mco2.70009","journal-title":"MedComm"},{"key":"12828_CR14","doi-asserted-by":"publisher","first-page":"113835","DOI":"10.1016\/j.addr.2021.113835","volume":"176","author":"W Ke","year":"2021","unstructured":"Ke W, Afonin KA (2021) Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs). Adv Drug Deliv Rev 176:113835. https:\/\/doi.org\/10.1016\/j.addr.2021.113835","journal-title":"Adv Drug Deliv Rev"},{"issue":"6478","key":"12828_CR15","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367(6478):eaau6977","journal-title":"Science"},{"issue":"1","key":"12828_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ajps.2021.05.006","volume":"17","author":"J Kim","year":"2022","unstructured":"Kim J, Li S, Zhang S, Wang J (2022) Plant-derived exosome-like nanoparticles and their therapeutic activities. Asian J Pharm Sci 17(1):53\u201369. https:\/\/doi.org\/10.1016\/j.ajps.2021.05.006","journal-title":"Asian J Pharm Sci"},{"issue":"5","key":"12828_CR17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/membranes12050498","volume":"12","author":"S Xie","year":"2022","unstructured":"Xie S, Zhang Q, Jiang L (2022) Current knowledge on exosome biogenesis, cargo-sorting mechanism and therapeutic implications. Membranes 12(5):498. https:\/\/doi.org\/10.3390\/membranes12050498","journal-title":"Membranes"},{"issue":"1","key":"12828_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","volume":"21","author":"QF Han","year":"2022","unstructured":"Han QF, Li WJ, Hu KS, Gao J, Zhai WL, Yang JH, Zhang SJ (2022) Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer 21(1):207","journal-title":"Mol Cancer"},{"issue":"4","key":"12828_CR19","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","volume":"56","author":"YJ Lee","year":"2024","unstructured":"Lee YJ, Shin KJ, Chae YC (2024) Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med 56(4):877\u2013889","journal-title":"Exp Mol Med"},{"issue":"1","key":"12828_CR20","doi-asserted-by":"publisher","first-page":"9566","DOI":"10.1038\/s41598-025-93120-3","volume":"15","author":"MAM Ali","year":"2025","unstructured":"Ali MAM, Matouk AI, Hamza AA, Amin A, Heeba GH (2025) Gallic and glycyrrhetinic acids prevent azithromycin-induced liver damage in rats by mitigating oxidative stress and inflammation. Sci Rep 15(1):9566. https:\/\/doi.org\/10.1038\/s41598-025-93120-3","journal-title":"Sci Rep"},{"key":"12828_CR21","doi-asserted-by":"publisher","first-page":"938471","DOI":"10.3389\/fphar.2022.938471","volume":"13","author":"L Lozon","year":"2022","unstructured":"Lozon L, Saleh E, Menon V, Ramadan WS, Amin A, El-Awady R (2022) Effect of safranal on the response of cancer cells to topoisomerase I inhibitors: Does sequence matter? Front Pharmacol 13:938471. https:\/\/doi.org\/10.3389\/fphar.2022.938471","journal-title":"Front Pharmacol"},{"issue":"12","key":"12828_CR22","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3390\/plants10122629","volume":"10","author":"E Ortega-Hern\u00e1ndez","year":"2021","unstructured":"Ortega-Hern\u00e1ndez E, Antunes-Ricardo M, Jacobo-Vel\u00e1zquez DA (2021) Improving the Health-Benefits of Kales (Brassica oleracea L. var. acephala DC) through the Application of Controlled Abiotic Stresses: A Review. Plants 10(12):2629. https:\/\/doi.org\/10.3390\/plants10122629","journal-title":"Plants"},{"issue":"2","key":"12828_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/nu14020245","volume":"14","author":"HA Alfawaz","year":"2022","unstructured":"Alfawaz HA, Wani K, Alrakayan H, Alnaami AM, Al-Daghri NM (2022) Awareness, knowledge and attitude towards \u2018superfood\u2019kale and its health benefits among Arab adults. Nutrients 14(2):245","journal-title":"Nutrients"},{"issue":"12","key":"12828_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s12032-023-02211-6","volume":"40","author":"N Orouji","year":"2023","unstructured":"Orouji N, Asl K, Taghipour S, Habtemariam Z, Nabavi S, S. M., Rahimi R (2023) Glucosinolates in cancer prevention and treatment: experimental and clinical evidence. Med Oncol 40(12):344. https:\/\/doi.org\/10.1007\/s12032-023-02211-6","journal-title":"Med Oncol"},{"issue":"21","key":"12828_CR25","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.3390\/molecules30214214","volume":"30","author":"A \u0141ukaszyk","year":"2025","unstructured":"\u0141ukaszyk A, Kwiecie\u0144 I, Kanik A, Blicharska E, Tatarczak-Michalewska M, Bia\u0142ow\u0105s W, Czarnek K, Szopa A (2025) Nutritional, Therapeutic, and Functional Food Perspectives of Kale (Brassica oleracea var. acephala): An Integrative Review. Molecules 30(21):4214. https:\/\/doi.org\/10.3390\/molecules30214214","journal-title":"Molecules"},{"issue":"1","key":"12828_CR26","doi-asserted-by":"publisher","first-page":"e2090","DOI":"10.1002\/biof.2090","volume":"51","author":"OK K\u0131rba\u015f","year":"2025","unstructured":"K\u0131rba\u015f OK, Sa\u011fra\u00e7 D, \u00c7ift\u00e7i \u00d6C et al (2025) Unveiling the potential: Extracellular vesicles from plant cell suspension cultures as a promising source. BioFactors 51(1):e2090","journal-title":"BioFactors"},{"key":"12828_CR27","doi-asserted-by":"publisher","first-page":"e202404734","DOI":"10.1002\/slct.202404734","volume":"10","author":"M Banerjee","year":"2025","unstructured":"Banerjee M, Rajeswari VD (2025) Plant-derived exosome-like nanoparticles from Elettaria cardamomum inhibit triple-negative breast cancer cell lines. ChemistrySelect 10:e202404734. https:\/\/doi.org\/10.1002\/slct.202404734","journal-title":"ChemistrySelect"},{"key":"12828_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12035-026-05820-0","volume":"63","author":"S Alhelwani","year":"2026","unstructured":"Alhelwani S, Degirmenci NS, Alt\u0131nta\u015f CM et al (2026) Comparative analysis of red onion-derived exosome-like nanovesicles and extract reveals sustained immunomodulatory effects in LPS\/IFN-\u03b3-stimulated microglia. Mol Neurobiol 63:533. https:\/\/doi.org\/10.1007\/s12035-026-05820-0","journal-title":"Mol Neurobiol"},{"issue":"6","key":"12828_CR29","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/biom14060656","volume":"14","author":"R-M Szilveszter","year":"2024","unstructured":"Szilveszter R-M, Muntean M, Florea A (2024) Molecular mechanisms in tumorigenesis of hepatocellular carcinoma and in target treatments\u2014An overview. Biomolecules 14(6):656. https:\/\/doi.org\/10.3390\/biom14060656","journal-title":"Biomolecules"},{"key":"12828_CR30","doi-asserted-by":"publisher","DOI":"10.18632\/genesandcancer.226","author":"BL Da","year":"2022","unstructured":"Da BL, Suchman KI, Lau L, Rabiee A, He AR, Shetty K, Yu H, Wong LL, Amdur RL, Crawford JM, Fox SS, Grimaldi GM, Shah PK, Weinstein J, Bernstein D, Satapathy SK, Chambwe N, Xiang X, Mishra L (2022) Pathogenesis to management of hepatocellular carcinoma. Genes Cancer. https:\/\/doi.org\/10.18632\/genesandcancer.226","journal-title":"Genes Cancer"},{"issue":"15","key":"12828_CR31","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1080\/10408398.2018.1454400","volume":"59","author":"D \u0160amec","year":"2019","unstructured":"\u0160amec D, Urli\u0107 B, Salopek-Sondi B (2019) Kale (Brassica oleracea var. acephala) as a superfood: Review of the scientific evidence behind the statement. Crit Rev Food Sci Nutr 59(15):2411\u20132422. https:\/\/doi.org\/10.1080\/10408398.2018.1454400","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"2","key":"12828_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.tips.2023.12.003","volume":"45","author":"Y-Y Zhang","year":"2024","unstructured":"Zhang Y-Y, Han Y, Li W-N, Xu R-H, Ju H-Q (2024) Tumor iron homeostasis and immune regulation. Trends Pharmacol Sci 45(2):145\u2013156. https:\/\/doi.org\/10.1016\/j.tips.2023.12.003","journal-title":"Trends Pharmacol Sci"},{"key":"12828_CR33","doi-asserted-by":"publisher","first-page":"778492","DOI":"10.3389\/fonc.2021.778492","volume":"11","author":"Q Guo","year":"2021","unstructured":"Guo Q, Li L, Hou S, Yuan Z, Li C, Zhang W, Zheng L, Li X (2021) The Role of Iron in Cancer Progression. Front Oncol 11:778492. https:\/\/doi.org\/10.3389\/fonc.2021.778492","journal-title":"Front Oncol"},{"issue":"6","key":"12828_CR34","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.3390\/ijms21062257","volume":"21","author":"S Forciniti","year":"2020","unstructured":"Forciniti S, Greco L, Grizzi F, Malesci A, Laghi L (2020) Iron metabolism in cancer progression. Int J Mol Sci 21(6):2257. https:\/\/doi.org\/10.3390\/ijms21062257","journal-title":"Int J Mol Sci"},{"issue":"17","key":"12828_CR35","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.7150\/thno.59092","volume":"11","author":"M Morales","year":"2021","unstructured":"Morales M, Xue X (2021) Targeting iron metabolism in cancer therapy. Theranostics 11(17):8412\u20138429. https:\/\/doi.org\/10.7150\/thno.59092","journal-title":"Theranostics"},{"issue":"4","key":"12828_CR36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3892\/mmr.2021.11940","volume":"23","author":"J Li","year":"2021","unstructured":"Li J, Wang X, Ma C, Xu S, Xu M, Yang J, Wang R, Xue L (2021) Dual PI3K\/mTOR inhibitor NVP-BEZ235 decreases the proliferation of doxorubicin-resistant K562 cells. Mol Med Rep 23(4):301. https:\/\/doi.org\/10.3892\/mmr.2021.11940","journal-title":"Mol Med Rep"},{"issue":"10","key":"12828_CR37","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.3390\/molecules25102454","volume":"25","author":"CC Yu","year":"2020","unstructured":"Yu CC, Huang SY, Chang SF, Liao KF, Chiu SC (2020) The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma. Molecules 25(10):2454. https:\/\/doi.org\/10.3390\/molecules25102454","journal-title":"Molecules"},{"key":"12828_CR38","doi-asserted-by":"publisher","first-page":"751079","DOI":"10.3389\/fcell.2021.751079","volume":"9","author":"H Chen","year":"2021","unstructured":"Chen H, Wang L, Zeng X, Schwarz H, Nanda HS, Peng X, Zhou Y (2021) Exosomes, a New Star for Targeted Delivery. Front Cell Dev Biology 9:751079. https:\/\/doi.org\/10.3389\/fcell.2021.751079","journal-title":"Front Cell Dev Biology"},{"issue":"5","key":"12828_CR39","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3390\/nano13050953","volume":"13","author":"S Elmehrath","year":"2023","unstructured":"Elmehrath S, Nguyen HL, Karam SM, Amin A, Greish YE (2023) BioMOF-based anti-cancer drug delivery systems. Nanomaterials 13(5):953. https:\/\/doi.org\/10.3390\/nano13050953","journal-title":"Nanomaterials"},{"key":"12828_CR40","doi-asserted-by":"publisher","first-page":"116543","DOI":"10.1016\/j.biopha.2024.116543","volume":"174","author":"C Bai","year":"2024","unstructured":"Bai C, Liu J, Zhang X, Li Y, Qin Q, Song H, Yuan C, Huang Z (2024) Research status and challenges of plant-derived exosome-like nanoparticles. Biomed Pharmacother 174:116543. https:\/\/doi.org\/10.1016\/j.biopha.2024.116543","journal-title":"Biomed Pharmacother"},{"issue":"15","key":"12828_CR41","doi-asserted-by":"publisher","first-page":"8170","DOI":"10.3390\/ijms22158170","volume":"22","author":"M Logozzi","year":"2021","unstructured":"Logozzi M, Di Raimo R, Mizzoni D, Fais S (2021) Nanovesicles from Organic Agriculture-Derived Fruits and Vegetables: Characterization and Functional Antioxidant Content. Int J Mol Sci 22(15):8170. https:\/\/doi.org\/10.3390\/ijms22158170","journal-title":"Int J Mol Sci"},{"key":"12828_CR42","doi-asserted-by":"publisher","first-page":"1100892","DOI":"10.3389\/fbioe.2022.1100892","volume":"10","author":"J Gao","year":"2023","unstructured":"Gao J, Li A, Hu J, Feng L, Liu L, Shen Z (2023) Recent developments in isolating methods for exosomes. Front Bioeng Biotechnol 10:1100892. https:\/\/doi.org\/10.3389\/fbioe.2022.1100892","journal-title":"Front Bioeng Biotechnol"},{"issue":"12","key":"12828_CR43","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1016\/j.bioactmat.2021.04.023","volume":"6","author":"JY You","year":"2021","unstructured":"You JY, Kang SJ, Rhee WJ (2021) Isolation of cabbage exosome-like nanovesicles and investigation of their biological activities in human cells. Bioactive Mater 6(12):4321\u20134332. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.04.023","journal-title":"Bioactive Mater"},{"key":"12828_CR44","doi-asserted-by":"publisher","first-page":"1223349","DOI":"10.3389\/fnut.2023.1223349","volume":"10","author":"H Zhu","year":"2023","unstructured":"Zhu H, He W (2023) Ginger: a representative material of herb-derived exosome-like nanoparticles. Front Nutr 10:1223349. https:\/\/doi.org\/10.3389\/fnut.2023.1223349","journal-title":"Front Nutr"},{"key":"12828_CR45","doi-asserted-by":"publisher","first-page":"875372","DOI":"10.3389\/fphar.2022.875372","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu X, Xu Y, Liang Q, Yang X, Huang J, Wang J, Zhang H, Shi J (2022) Recent Advances in Dual PI3K\/mTOR Inhibitors for Tumour Treatment. Front Pharmacol 13:875372. https:\/\/doi.org\/10.3389\/fphar.2022.875372","journal-title":"Front Pharmacol"},{"issue":"24","key":"12828_CR46","doi-asserted-by":"publisher","first-page":"17255","DOI":"10.18632\/oncotarget.25063","volume":"9","author":"F Shi","year":"2018","unstructured":"Shi F, Zhang J, Liu H, Wu L, Jiang H, Wu Q, Liu T, Lou M, Wu H (2018) Correction: The dual PI3K\/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo. Oncotarget 9(24):17255. https:\/\/doi.org\/10.18632\/oncotarget.25063","journal-title":"Oncotarget"},{"key":"12828_CR47","doi-asserted-by":"publisher","unstructured":"Al Mansoori A, Baig B, Harati R et al (2026) Safranal improves the anticancer efficacy of sorafenib via transcriptomic reprogramming and metabolomic changes in a rat model of diethylnitrosamine-induced cirrhosis-hepatocellular carcinoma. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology. Advance online publication https:\/\/doi.org\/10.1007\/s00210-026-05573-6","DOI":"10.1007\/s00210-026-05573-6"},{"key":"12828_CR48","doi-asserted-by":"publisher","first-page":"1526206","DOI":"10.3389\/fonc.2025.1526206","volume":"15","author":"Z Ding","year":"2025","unstructured":"Ding Z, Wang L, Sun J, Zheng L, Tang Y, Tang H (2025) Hepatocellular carcinoma: Pathogenesis, molecular mechanisms, and treatment advances. Front Oncol 15:1526206. https:\/\/doi.org\/10.3389\/fonc.2025.1526206","journal-title":"Front Oncol"},{"issue":"11","key":"12828_CR49","doi-asserted-by":"publisher","first-page":"286","DOI":"10.31083\/j.fbl2811286","volume":"28","author":"Y Li","year":"2023","unstructured":"Li Y, Yu Y, Yang L, Wang R (2023) Insights into the role of oxidative stress in hepatocellular carcinoma development. Front Bioscience\u2013Landmark 28(11):286. https:\/\/doi.org\/10.31083\/j.fbl2811286","journal-title":"Front Bioscience\u2013Landmark"},{"issue":"2","key":"12828_CR50","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/antiox13020208","volume":"13","author":"S Gensluckner","year":"2024","unstructured":"Gensluckner S, Wernly B, Datz C, Aigner E (2024) Iron, oxidative stress, and metabolic dysfunction-associated steatotic liver disease. Antioxidants 13(2):208. https:\/\/doi.org\/10.3390\/antiox13020208","journal-title":"Antioxidants"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12828-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12828-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12828-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:04:11Z","timestamp":1790643851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12828-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12828"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12828-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"22 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1652"}}